BioPharma Dive
Media & Internet · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
90 State St, Albany, New York, 12207, Un...Phone Number
(202) 331-2480Website
www.biopharmadive.comRevenue
$13.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About BioPharma Dive
BioPharma Dive is a publication that provides news and analysis specifically tailored for executives in the biotech and biopharmaceutical industries. The platform covers a wide range of topics including clinical trials, drug discovery and development, pharma marketing, and FDA regulations. Its intended clients are professionals and decision-makers within the biotech and pharmaceutical sectors seeking to stay informed about industry trends and developments. BioPharma Dive also offers a free newsletter to keep subscribers updated on the latest news and insights.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioPharma Dive your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if BioPharma Dive is spiking on competitors!
Funding: Get notified immidiatlly once BioPharma Dive has new funding data
Check if BioPharma Dive has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
BioPharma Dive, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when BioPharma Dive launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on BioPharma Dive recently announced quarterly report
Click to see if BioPharma Dive had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at BioPharma Dive
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to BioPharma Dive
Compare insights from companies similar to BioPharma Dive, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
BioPharma Dive
$13.4M
51-200
Private
$42M
2014
N/A
Company Profile Activity
Activity Insights
BioPharma Dive is experiencing very low activity levels compared to other companies in the Media & Internet sector.
What does this means?
BioPharma Dive is drawing exceptional interest within the Media & Internet industry, suggesting notable developments or strong market momentum, learn more about BioPharma Dive.
BioPharma Dive financials insights
Gather financial insights about BioPharma Dive, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$42M
BioPharma Dive Tech Stack
A closer look at the technologies used by BioPharma Dive
BioPharma Dive News & Media
Cytospire hauls in $83M for a new type of T cell engager | BioPharma Dive
The British biotechnology startup is making "pan-gamma delta” T cell engagers it says can address the limitations of similar, existing therapies.Evotec, Vistagen lay off staff; Immutep shares collapse on study failure | BioPharma Dive
Evotec will cut 800 employees in its second layoff round since 2024. Elsewhere, Ultragenyx got a needed win and a twice-rejected cell therapy is getting an audience at the FDA.BioNTech founders to step down and helm new mRNA startup - BioPharma Dive
Ugur Sahin and Özlem Türeci, who directed the COVID vaccine maker’s rise to prominence, will helm an as-yet-unnamed company dedicated to mRNA discovery work.Ipsen to withdraw cancer drug acquired in buyout due to safety concerns | BioPharma Dive
Ipsen found cases of secondary malignancies in a confirmatory study of Tavzerik, a medicine it got in a purchase of Epizyme and that it has struggled to sell.
Read more news
Top Media & Internet Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioPharma Dive
Sign Up For FreeTo access detailed company insights
BioPharma Dive is a publication that provides news and analysis specifically tailored for executives in the biotech and biopharmaceutical industries. The platform covers a wide range of topics including clinical trials, drug discovery and development, pharma marketing, and FDA regulations. Its intended clients are professionals and decision-makers... Read More
